First Time Loading...

Tandem Diabetes Care Inc
NASDAQ:TNDM

Watchlist Manager
Tandem Diabetes Care Inc Logo
Tandem Diabetes Care Inc
NASDAQ:TNDM
Watchlist
Price: 37.51 USD 6.44% Market Closed
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

TNDM Price Targets Summary
Tandem Diabetes Care Inc

Wall Street analysts forecast TNDM stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TNDM is 36.65 USD with a low forecast of 18.18 USD and a high forecast of 63 USD.

TNDM Lowest Forecast
Wall Street Target
18.18 USD
52% Downside
TNDM Average Forecast
Wall Street Target
36.65 USD
2% Downside
TNDM Highest Forecast
Wall Street Target
63 USD
68% Upside
Lowest
Price Target
18.18 USD
52% Downside
Average
Price Target
36.65 USD
2% Downside
Highest
Price Target
63 USD
68% Upside

TNDM Last Price Targets
Tandem Diabetes Care Inc

The latest public price target was made on Apr 25, 2024 by Danielle AntalffyMike Kratky from Leerink Partners , who expects TNDM stock to rise by 20% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Danielle AntalffyMike Kratky
Leerink Partners
45 USD
Upside 20%
4 days ago
Apr 25, 2024
Leerink Partners Upgrades Tandem Diabetes Care (TNDM) to Outperform
StreetInsider
Matthew Blackman
Stifel Nicolaus
40 USD
Upside 7%
1 week ago
Apr 22, 2024
Tandem Diabetes Care (TNDM) PT Raised to $40 at Stifel
StreetInsider
Kenneth Leon
CFRA
36 USD
Downside 4%
2 weeks ago
Apr 11, 2024
Tandem Diabetes Care (TNDM) PT Raised to $36 at CFRA
StreetInsider
Mathew Blackman
Stifel Nicolaus
37 USD
Downside 1%
1 month ago
Mar 25, 2024
Tandem Diabetes upgraded to Buy at Stifel on strong Mobi adoption
TheFly
Danielle AntalffyMike Kratky
Leerink Partners
Price Target 45 USD
Upside/Downside 20%
View Source
Matthew Blackman
Stifel Nicolaus
Price Target 40 USD
Upside/Downside 7%
View Source
Kenneth Leon
CFRA
Price Target 36 USD
Upside/Downside 4%
View Source
Mathew Blackman
Stifel Nicolaus
Price Target 37 USD
Upside/Downside 1%
View Source
Tandem Diabetes Care Inc Competitors:
Price Targets
NSCI
Nanalysis Scientific Corp
178% Upside
A
688617
APT Medical Inc
11% Downside
R
REG1V
Revenio Group Oyj
14% Upside
ARJO B
Arjo AB (publ)
16% Upside
NSCI
Nanalysis Scientific Corp
178% Upside
A
688617
APT Medical Inc
11% Downside
R
REG1V
Revenio Group Oyj
14% Upside
ARJO B
Arjo AB (publ)
16% Upside
PODD
Insulet Corp
44% Upside
BIM
Biomerieux SA
12% Upside
SN
Smith & Nephew PLC
33% Upside
ABT
Abbott Laboratories
20% Upside

Revenue
Forecast

Revenue Estimate
Tandem Diabetes Care Inc

For the last 8 years the compound annual growth rate for Tandem Diabetes Care Inc's revenue is 34%. The projected CAGR for the next 3 years is 12%.

34%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Tandem Diabetes Care Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Tandem Diabetes Care Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-29%
Average Miss
What are analyst estimates?

See Also

Summary
TNDM intrinsic value, competitors valuation, and company profile.
DCF Valuation
TNDM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TNDM stock valuation using valuation multiples.
Wall Street Estimates
TNDM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TNDM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TNDM's stock price target?
Price Target
36.65 USD

According to Wall Street analysts, the average 1-year price target for TNDM is 36.65 USD with a low forecast of 18.18 USD and a high forecast of 63 USD.

What is Tandem Diabetes Care Inc's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Tandem Diabetes Care Inc's revenue is 34%. The projected CAGR for the next 3 years is 12%.

ALPHA SPREAD
Join more than 132,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.